10.1          License Agreement
                           EXCLUSIVE LICENSE AGREEMENT

         This EXCLUSIVE LICENSE AGREEMENT ("Agreement") is made this 30th day of
December  1998  between  DenexCorp/LVPS  MicroFacility,   a  Nevada  Corporation
("LICENSOR"), and LVPS MicroFacility, Inc., a Delaware corporation ("LICENSEE").

         WHEREAS,  LICENSOR has conducted extensive market feasibility  studies,
spent  significant  resources  on the concept,  design,  patent,  and  trademark
relating to Modular Pharmaceutical  Solution Manufacturing for the production of
Large Volume Parenteral Solutions; and

         WHEREAS, LICENSEE desires to obtain the exclusive use of the patent and
trademark  relating  to  Modular  Pharmaceutical   Solution  Manufacturing  from
LICENSOR; and

         WHEREAS,  LICENSOR  is  willing to enter  into an  exclusive  licensing
agreement with LICENSEE, subject to the terms and conditions of this Agreement.

NOW THEREFORE,  in  consideration  of the recital set forth above and other good
and valuable consideration, the receipt and sufficiency of which is acknowledge,
the parties agree as follows.

1.       Term.

         The term of this Agreement shall be ten (10) years.

2.       Exclusivity.

         During  the  term of this  Agreement,  so long  as  LICENSEE  pays  the
royalties set forth below,  LICENSEE shall have the exclusive use of any and all
patents and trademarks of LICENSOR relating to Modular  Pharmaceutical  Solution
Manufacturing (the "Intellectual Property").

3.       Payments.

         a. Royalty.  During the term of this  Agreement,  LICENSEE shall pay to
LICENSOR as a royalty (the "Royalty") an amount equal to two percent (2%) of the
gross  selling  price  on  each  MicroFacility  sold  during  the  term  of this
Agreement.

4.       Manner of Payment.

         a.  Payment.  Not later than the tenth (10th) day after the end of each
and every quarter,  beginning with June 30, 1999, LICENSEE shall pay and deliver
to LICENSOR the Royalty.

         b. Prompt  Delivery.  LICENSEE  acknowledges and agrees that the timely
delivery of the payments  required by Section 4a and the  Quarterly  Reports and
Sales  Reports  required by Section 5 hereof are  essential  to this  Agreement.
Interest shall accrue on all past due payments  hereunder from their  respective
due dates until paid at the rate of one percent (1%) per month,  or if such rate
exceeds the maximum rate allowed by law, at the maximum rate allowed by law, and
shall be payable on demand.

5.       Reports, Record Keeping And Audits.

         a.  Maintenance  of Records.  LICENSEE  shall keep books of account and
records  in  accordance   with   generally   accepted   accounting   principles,
consistently  applied,  covering all sales  relating to this  Agreement  and the
license  hereby  granted.  Such records shall be maintained for at least two (2)
years after the quarter to which such records relate.

         b.  Quarterly  Reports.  Every Royalty  payment  pursuant to Section 4a
shall be accompanied by a written report  (individually,  the "Quarterly Report"
and collectively, the "Quarterly Reports").



         c. Sales Reports.  In addition,  LICENSEE  shall provide  LICENSOR with
monthly  sales recap  reports and seasonal  sales  projections  as developed and
revised (collectively,  the "Sales Reports");  provided,  however, that all such
Sales  Reports  shall be in the form and format used by LICENSEE in the ordinary
course of business.

         d. Audit.  LICENSOR and its duly authorized  representatives shall have
the right upon  reasonable  notice and at all  reasonable  hours  during  normal
business  days to examine  and copy such books of account  and  records  and all
other documents and materials in the possession or under the control of LICENSEE
with respect to the subject matter and the terms of this Agreement,  the cost of
which shall be borne by LICENSOR.  LICENSOR shall not conduct an audit more than
once with  respect to any  calendar  year,  and in no event  shall such audit be
during LICENSEE'S fourth fiscal quarter. If the audit discloses that the Royalty
payments  actually due exceed the Royalty payments paid,  LICENSEE shall pay the
unpaid  Royalty and interest on such unpaid Royalty  payments  computed from the
date such Royalty payments were due, accrued at the rate of one percent (1%) per
month,  or if such rate exceeds the maximum rate allowed by law, at such maximum
legal rate. If the audit  discloses  that the Royalty  payments made by LICENSEE
exceed the Royalty payments due, LICENSOR shall reimburse LICENSEE in the amount
the overpaid  Royalty and interest on such  overpayment,  computed from the date
such  Royalty  payments  were made,  accrued at the rate of one percent (1%) per
month. In addition,  if the audit discloses that the Royalty  payments  actually
due exceed the Royalty payments paid by an amount greater than five percent (5%)
of the Royalty  payments paid, the cost of the audit performed by LICENSOR shall
be paid by LICENSEE.

         e. Financial  Statements.  If, at any time during the term, LICENSEE is
not a company required to provide public financial  information  pursuant to the
Securities and Exchange Commission reporting requirements,  LICENSEE shall, upon
reasonable  request  of  LICENSOR,  and from  time to time  thereafter,  provide
LICENSOR with interim and audited annual financial statements.

6.       Protection of Intellectual Property

         a. Acknowledgments and Agreements of LICENSEE. As a material inducement
to  LICENSOR  to  enter  into  this  Agreement,  and as a  material  part of the
consideration  to LICENSOR  hereunder,  LICENSEE hereby  acknowledges and agrees
that:

                  (i) (a)  LICENSOR  owns the  Intellectual  Property in various
                  countries   worldwide,   and   all   rights,    registrations,
                  applications  and filings  with  respect to such  Intellectual
                  Property,   and  all  renewals  and  extensions  of  any  such
                  registrations,  applications and filings, (b) LICENSOR has the
                  right to license the Intellectual  Property,  and (c) LICENSEE
                  is  acquiring  hereby  only the right to use the  Intellectual
                  Property  for the purpose  stated in and pursuant to the terms
                  and conditions of the Agreement.

                  (ii) (a) Great value is placed on the  Intellectual  Property,
                  and the goodwill  associated  therewith,  (b) the Intellectual
                  Property  and  all  rights  therein  and  goodwill  pertaining
                  thereto belong exclusively to LICENSOR, and (c) all authorized
                  use of the  Intellectual  Property by LICENSEE  shall inure to
                  the benefit of LICENSOR.

                  (iii)  The  conditions,  terms,  restrictions,  covenants  and
                  limitations  of  this  Agreement  are  necessary,   equitable,
                  reasonable  and essential to assure the consuming  public that
                  all goods sold under the Intellectual Property are of the same
                  consistently  high  quality as sold by LICENSOR  and by others
                  who are  licensed  to  design,  manufacture  and/or  sell  any
                  products by, under or with the Intellectual Property, if any.

         b.       Protection of Rights.

                  (i)  Restriction on Use.  LICENSEE shall not use or permit the
                  use of the Intellectual  Property for any purpose or use other
                  than the uses licensed under this Agreement.

                  (ii) General. LICENSEE shall cooperate fully and in good faith
                  with  LICENSOR  for the  purpose of  securing  and  preserving
                  LICENSOR's (or any grantee of LICENSOR's) rights in and to the
                  Intellectual Property.



7.       Defaults And Remedies.

         a.  Defaults  by  LICENSEE.  The  occurrence  of any one or more of the
following shall constitute a default by LICENSEE under this Agreement:

                  (i)  LICENSEE  shall  fail to make  any  payment,  submit  any
                  Quarterly Report or provide any financial information required
                  under this Agreement when due, and such failure  continues for
                  more than  thirty  (30) days  after  written  notice  thereof,
                  unless such  failure  cannot be cured  within such thirty (30)
                  day  period and  LICENSEE  shall  have  commenced  to cure the
                  failure  and  proceeds  diligently  thereafter  to  cure  such
                  failure.

                  (ii)  LICENSEE  uses the  Intellectual  Property in any manner
                  likely to endanger the validity of the  Intellectual  Property
                  or to  damage  or  impair  the  reputation  or  value  of  the
                  Intellectual Property, and such action continues for more than
                  thirty  (30) days after  written  notice  thereof,  unless the
                  action  cannot be cured within such thirty (30) day period and
                  LICENSEE  shall have commenced to cure the action and proceeds
                  diligently thereafter to cure such action.

                  (iii) The  failure of  LICENSEE  to  perform  any of its other
                  material  obligations  under this  Agreement  and such failure
                  continues for more than thirty (30) days after written  notice
                  thereof, unless the failure cannot be cured within such thirty
                  (30) day period and LICENSEE  shall have commenced to cure the
                  failure  and  proceeds  diligently  thereafter  to  cure  such
                  failure.

         b.  Default  by  LICENSOR.  If  LICENSOR  fails to  perform  any of its
material  obligations  under this Agreement and such failure  continues for more
than thirty (30) days after the  written  notice  thereof,  such  failure  shall
constitute a failure by LICENSOR under this Agreement, unless the failure cannot
be cured within such thirty (30) day-period and LICENSOR shall have commenced to
cure such failure and proceeds diligently thereafter to cure such failure.

         c.       Remedies.

                  (i)  If   LICENSEE   has  not   cured   any  such   breach  or
                  non-performance  in  accordance  with  Section  7a  above,  in
                  addition  to  all  other  rights  and  remedies  available  to
                  LICENSOR,  whether  pursuant to the terms of this Agreement at
                  law in equity or otherwise,  LICENSOR  shall have the right to
                  terminate this Agreement without further notice to LICENSEE.

                  (ii)  If   LICENSOR   has  not  cured   any  such   breach  or
                  non-performance  in  accordance  with  Section  7b  above,  in
                  addition to all of the other rights and remedies  available to
                  LICENSEE,  whether  pursuant to the terms of this Agreement at
                  law, in equity or otherwise,  LICENSEE shall have the right to
                  terminate this Agreement without further notice to LICENSOR.

         d. Effect of Expiration or Termination. Except as specifically provided
herein to the contrary,  upon expiration or termination of this  Agreement,  the
rights and licenses  granted  herein shall  terminate and LICENSEE shall have no
further right to use the  Intellectual  Property.  Upon the request of LICENSOR,
LICENSEE  shall   immediately   execute  without  further   consideration   such
assignments and other instruments which may be required to be recorded to effect
the  termination of the licenses and rights granted herein (and the  assignments
of LICENSEE's rights to LICENSOR).  Within twenty (20) days of the expiration or
termination  of this  Agreement,  LICENSEE  shall deliver to LICENSOR all unpaid
Royalties together with a final Quarterly Report covering all sales from the end
of the period  covered by the  preceding  Quarterly  Report  through the date of
expiration or termination of this Agreement.

8.       Warranties.

         a. LICENSOR  warrants and represents that LICENSOR (i) is free to enter
into this  Agreement,  (ii) has the full power,  right and authority to make the
grant of rights to  LICENSEE  as  provided  hereunder  and that the  exercise by
LICENSEE of such rights, as authorized  hereunder,  shall not violate the rights
of any third  party,  and (iii) is not subject to any  obligation  which will or
might hinder or prevent the full  completion and  performance by LICENSOR of any
of the  covenants  and the  conditions  to be kept  and  performed  by  LICENSOR
hereunder.



         b. LICENSEE hereby represents and warrants that LICENSEE (i) is free to
enter into this Agreement,  (ii) is not subject to any obligation  which will or
might hinder or prevent the full  completion and  performance by LICENSEE of any
of the covenants and conditions to be kept and performed by LICENSEE  hereunder,
and (iii) will ensure that all uses of the Intellectual Property comply with the
terms of this Agreement.

9.       General Provisions.

         a. Entire  Agreement.  This Agreement  sets forth the entire  agreement
between the Parties with  respect to the subject  matter  hereof,  and all prior
negotiations,  discussions,  commitments and/or understandings relating thereto,
if any, are merged  herein.  This  Agreement  shall  supersede any and all other
agreements  between the Parties and may be modified only by a written  agreement
signed by duly authorized of each of the Parties.  No  representations,  oral or
otherwise expressed or implied,  other than those specifically contained in this
Agreement have been made by any party hereto.  No other  agreements not referred
to or specifically contained herein, oral or otherwise, shall be deemed to exist
or to bind any of the Parties hereto.

         b.  Successors and Assigns.  This  Agreement  shall be binding upon and
shall  inure to the  benefit  of the  successors  and  permitted  assigns of the
Parties.

         c. Choice of Law. The validity,  construction  and  enforcement of this
Agreement  shall be  governed  by the laws of the  State of  California  without
regard to its choice of law principles.

         d.  Dispute  Resolution.  Any claim or  controversy  arising  out of or
relating to this  Agreement,  or any breach  thereof  wherein  only  damages are
sought,  shall be settled by the  appointment of a retired judge of the Superior
or Appellate Courts of California who shall act pursuant to Section 638.1 of the
California  Code of  Civil  Procedure  "to try any and all of the  issues  in an
action  or  proceeding,  whether  of fact or of law,  and to  report  a state of
decision thereon".  The Parties stipulate to the use of the referenced procedure
and agree that the Superior  Court of Orange  County of the State of  California
may issue such orders as are necessary to implement the Parties  intent that any
such claim or  controversy  shall be resolved  through the use of the referenced
procedure. The decision reached by the referee shall be entered as a judgment of
the Superior  Court  appointing  the referee and such  decisions  shall be fully
appealable.  All fees and expenses of the referee shall be initially  borne on a
pro rata basis by the Parties, but shall be recoverable by the prevailing party.
Additionally,  the prevailing party shall be entitled to recover,  as an element
of such  party's  cost of suit,  and not as damages,  all  reasonable  costs and
expenses  incurred or sustained by such prevailing party in connection with such
actions including without limitation, legal fees and costs.

         e. No Waiver. No waiver by either party, whether express or implied, of
any provision of this Agreement or of any breach or default of any party,  shall
constitute a continuing waiver of such provision or any other provisions of this
Agreement,  and no such waiver by any party shall prevent such party from acting
upon the same or any subsequent breach or default of the other party of the same
or any other provision of this Agreement.

         f.  Disclaimer  of Agency.  Nothing in this  Agreement  shall  create a
partnership  or joint  venture or establish  the  relationship  of principal and
agent or any other  relationship of a similar nature between the parties hereto,
and neither  LICENSEE nor LICENSOR  shall have the power to obligate or bind the
other in any manner whatsoever.

         g.  Construction.  This  Agreement  shall  be  interpreted  to  provide
LICENSOR  with the  maximum  control of the  Intellectual  Property  and the use
thereof.

         h. Licensor  Approvals.  Any approval required from LICENSOR under this
Agreement  shall be  effective  and binding  against  LICENSOR  only if it is in
writing.  Any approval required  hereunder must be obtained by LICENSEE prior to
LICENSEE taking any action which requires such approval.

         i. This Agreement may be executed in any number of  counterparts,  each
of which shall be deemed an original, but all of which together shall constitute
one and the same instrument.

         j.  Authority.  Each  individual  signing  on behalf of a party  hereto
represents  and warrants that he or she is authorized to execute this  Agreement
on behalf of such party.



         k.  Termination on Insolvency of LICENSEE.  LICENSOR may terminate this
Agreement if a petition for relief under  applicable  bankruptcy law is filed by
or against LICENSEE, and is not dismissed within sixty (60) days of such filing,
if  LICENSEE  makes any  assignment  for the benefit of its  creditors,  or if a
receiver is appointed for LICENSEE for all or substantially  are of its business
interests. The license and rights granted hereunder are personal to LICENSEE. No
assignee for the benefit of creditors,  receiver, debtor in possession,  trustee
in  bankruptcy,  sheriff or any other  officer of court charged with taking over
custody  of  LICENSEE's  assets or  business  shall  have any right to  continue
performance  to  exploit  or in any way use the  Intellectual  Property  if this
Agreement is terminated, except as may be required by law.

         l.  Termination on Insolvency of LICENSOR.  LICENSEE may terminate this
Agreement,  if a petition for relief under applicable bankruptcy law is filed by
or against LICENSOR, and is not dismissed within sixty (60) days of such filing,
if  LICENSOR  makes any  assignment  for the benefit of its  creditors,  or if a
receiver is appointed for LICENSOR for all or substantially  all of its business
interests.  In the event of such  termination,  LICENSEE shall have the right to
continue thereafter to import and/or sell any and all Merchandise which LICENSEE
has  purchased,  produced  or  committed  to  purchase  prior  to  the  date  of
termination.

IN WITNESS  WHEREOF the parties have executed this  Agreement as of the date set
forth above.

                                        DenexCorp/LVPS MicroFacility

                                        By:  /s/  Ronald R. Patterson
                                        Name:     Ronald R. Patterson
                                        Title:    Chief Executive Officer

                                        LVPS MicroFacility, Inc.

                                        By:  /s/  Ross T. Boling
                                        Name:     Ross T. Boling
                                        Title:    Chief Operating Officer